With a background in journalism and counseling, Penny Min blends analytical research with real-world insight to help readers make informed financial decisions. At Forbes Marketplace, she specializes ...
By 2050, an estimated 50% of the world's population will be nearsighted, and nearly a billion people will suffer from severe ...
As the rate of myopia in children grows, research is keeping a finger pointed at the fact much of our lives is spent indoors. Jessica was a writer on the Wellness team, with a focus on health ...
The United States is fast becoming a nearsighted nation: More than 40% of Americans have myopia, and the number is climbing fast, especially for children. Experts aren’t sure why, but they believe ...
SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Many people believe wearing spectacles makes eyes weaker, but doctors say this is a myth. An ophthalmologist explains how ...
- First and only FDA-approved orthokeratology contact lens for myopia management. - Available in sphere and toric designs to correct various combinations of corneal shapes and refractive errors.
Wearing corrective lenses is one of the most effective ways to manage early-onset myopia. Beyond providing a clearer vision, ...
Please provide your email address to receive an email when new articles are posted on . CooperCompanies and EssilorLuxottica announced a partnership to accelerate commercialization of SightGlass ...
Myopia, a common vision issue, is often surrounded by myths. This article debunks misconceptions about myopia, clarifying that it's a refractive disorder, not a disease. It emphasizes that myopia ...
SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (Kubota Vision), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results